Cardiothoracic surgeons are studying the use of artificial intelligence (AI) and machine learning (ML) to improve risk prediction in the hopes that patient outcomes also will improve. Arman Kilic, MD, and Ara A. Vaporciyan, MD, along with medical student Brian Ayers, discuss what AI and ML mean, how it can uncover previously unknown relationships in medical data, and how it can be used to assist the surgeon in the operating room.

Cardiothoracic surgeons are studying the use of artificial intelligence (AI) and machine learning (ML) to improve risk prediction in the hopes that patient outcomes also will improve.
15 min.

2020 STS Annual Meeting Lillehei Lecture
Bumper Car Innovation of Heart Pumps and Mechanical Lungs

The STS Lillehei Lecture was established in 2009 through a generous gift from the Lillehei Family Charitable Foundation in honor of Dr. C. Walton Lillehei, a pioneer in open heart surgery utilizing cross circulation.

In the latest episode, Drs. Robert Kormos and David Morales join host Dr. Thomas K. Varghese Jr. to explore the motivation for developing registries that examine clinical outcomes and quality-of-life metrics for patients who received FDA-approved durable mechanical circulatory support devices.
38 min.

Artificial intelligence (AI) and electronic health technologies are changing how physicians conceptualize and treat diseases. Although these futuristic advancements are leading to improvements in quality, safety, and patient outcomes, these technologies also are dramatically changing the cyber threat landscape. Kevin W.

Artificial intelligence and electronic health technologies are changing how physicians conceptualize and treat diseases.
18 min.

Lung cancer morbidity and mortality remains high in the United States and beyond despite major changes over the past few years in early detection and treatment for advanced disease. Dr. Douglas E. Wood, from the University of Washington in Seattle, moderates a roundtable discussion with prominent lung cancer surgeons—Drs. Shanda H. Blackmon, Lisa M. Brown, and Mitchell J.

Lung cancer morbidity and mortality remains high in the United States and beyond despite major changes over the past few years in early detection and treatment for advanced disease.
25 min.

New technologies and innovative treatments are making it easier to successfully diagnose and treat patients with lung cancer. Douglas E. Wood, MD (University of Washington) moderates a discussion with Leah Backhus, MD, MPH (Stanford University), Elizabeth David, MD (UC Davis), and Moishe Liberman, MD, PhD (University of Montreal) about how low-dose computed tomography, wearable devices, energy-sealing devices, and robots are changing patient outcomes and experiences.

The volumes of two aortic valve replacements (AVR) procedures have changed dramatically over the past few years, with more transcatheter procedures now being performed than open surgical procedures. Four cardiac surgeons discuss the evolving trends in TAVR, why the changes are occurring, and what’s ahead for TAVR and SAVR. Wilson Y. Szeto, MD (University of Pennsylvania) moderates the discussion that also features Michael J. Mack, MD (The Heart Hospital Baylor Plano), John V. Conte, MD (Penn State University), and Thomas E. MacGillivray, (Houston Methodist).

Health care professionals tend to be traditional and conservative when it comes to practice, so incorporating new technologies and innovations into the hospital and the operating room can be a challenge. Four cardiothoracic surgery change drivers — Shanda Blackmon, MD, MPH (Mayo Clinic), James Luketich, MD (UPMC Presbyterian), T. Sloan Guy, MD, MBA (Weill Cornell Medical Medicine), and Linda W. Martin, MD, MPH (University of Virginia) — provide advice on how to get buy-in from hospital administrators, as well as team members.

Healthcare professionals tend to be traditional and conservative when it comes to practice, so incorporating new technologies and innovations into the hospital and the operating room can be a challenge.
12 min.